{"id":"https://openalex.org/W2953620378","doi":"https://doi.org/10.1158/1538-7445.am2019-4981","title":"Abstract 4981: HER2-targeted antibody drug conjugates (ADCs) induce host immunity against cancer stem cells and are enhanced by anti-PD-L1","display_name":"Abstract 4981: HER2-targeted antibody drug conjugates (ADCs) induce host immunity against cancer stem cells and are enhanced by anti-PD-L1","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2953620378","doi":"https://doi.org/10.1158/1538-7445.am2019-4981","mag":"2953620378"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-4981","doi":"https://doi.org/10.1158/1538-7445.am2019-4981","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-4981","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042358107","display_name":"Leiming Xia","orcid":"https://orcid.org/0000-0002-6760-0153","observed_orcids":["https://orcid.org/0000-0002-6760-0153"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leiming Xia","raw_affiliation_strings":["1Univ. of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046908034","display_name":"Lu Wen","orcid":"https://orcid.org/0000-0002-1773-1876","observed_orcids":["https://orcid.org/0000-0002-1773-1876"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lu Wen","raw_affiliation_strings":["1Univ. of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055613434","display_name":"Gang Wu","orcid":"https://orcid.org/0000-0002-9852-7585","observed_orcids":["https://orcid.org/0000-0002-9852-7585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Wu","raw_affiliation_strings":["2Cancer Center, Wuhan, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Center, Wuhan, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100375846","display_name":"Tao Zhang","orcid":"https://orcid.org/0000-0002-8157-7674","observed_orcids":["https://orcid.org/0000-0002-8157-7674"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tao Zhang","raw_affiliation_strings":["2Cancer Center, Wuhan, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Center, Wuhan, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066044417","display_name":"Frank I. Comer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Comer","raw_affiliation_strings":["3MedImmune, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MedImmune, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083508937","display_name":"Mary Jane Hinrichs","orcid":"https://orcid.org/0000-0002-3816-2334","observed_orcids":["https://orcid.org/0000-0002-3816-2334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Jane Masson Hinrichs","raw_affiliation_strings":["4MedImmune, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4MedImmune, Bethesda, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065880126","display_name":"Michael D. Oberst","orcid":"https://orcid.org/0009-0006-9529-6925","observed_orcids":["https://orcid.org/0009-0006-9529-6925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Oberst","raw_affiliation_strings":["3MedImmune, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MedImmune, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006003927","display_name":"Steven R. Coats","orcid":"https://orcid.org/0009-0002-7030-2840","observed_orcids":["https://orcid.org/0009-0002-7030-2840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R. Coats","raw_affiliation_strings":["3MedImmune, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MedImmune, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104109531","display_name":"Alfred E. Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alfred E. Chang","raw_affiliation_strings":["1Univ. of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100405063","display_name":"Yuanyuan Liu","orcid":"https://orcid.org/0000-0003-0113-2438","observed_orcids":["https://orcid.org/0000-0003-0113-2438"]},"institutions":[{"id":"https://openalex.org/I4210165047","display_name":"Hefei First People's Hospital","ror":"https://ror.org/05qwgjd68","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210165047"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuanyuan Liu","raw_affiliation_strings":["5The First People\u2019s Hospital of Hefei, Hefei, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5The First People\u2019s Hospital of Hefei, Hefei, China","institution_ids":["https://openalex.org/I4210165047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110364989","display_name":"Yangyi Bao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165047","display_name":"Hefei First People's Hospital","ror":"https://ror.org/05qwgjd68","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210165047"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yangyi Bao","raw_affiliation_strings":["5The First People\u2019s Hospital of Hefei, Hefei, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5The First People\u2019s Hospital of Hefei, Hefei, China","institution_ids":["https://openalex.org/I4210165047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059956218","display_name":"Max S. Wicha","orcid":"https://orcid.org/0000-0003-4180-7727","observed_orcids":["https://orcid.org/0000-0003-4180-7727"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Max Wicha","raw_affiliation_strings":["1Univ. of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100393720","display_name":"Qiao Li","orcid":"https://orcid.org/0000-0003-4321-2647","observed_orcids":["https://orcid.org/0000-0003-4321-2647"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiao Li","raw_affiliation_strings":["1Univ. of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"4981","last_page":"4981"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.4323999881744385,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-targeted-antibody-drug-conjugates","display_name":"HER2-targeted antibody-drug conjugates","score":0.875},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7300000190734863},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6639999747276306},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8809999823570251},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8809999823570251},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.5329999923706055},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9359999895095825},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4440000057220459},{"id":"https://openalex.org/keywords/aldh-positive-cells","display_name":"ALDH-positive cells","score":0.5529999732971191},{"id":"https://openalex.org/keywords/immunocompetent-mouse-model","display_name":"immunocompetent mouse model","score":0.7089999914169312},{"id":"https://openalex.org/keywords/4t1-cells","display_name":"4T1 cells","score":0.7360000014305115},{"id":"https://openalex.org/keywords/tumor-specific-t-cells","display_name":"tumor-specific T cells","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7162191867828369},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6084079742431641},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5929999351501465},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.539912223815918},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5061728358268738},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4831368625164032},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4822410047054291},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4589783251285553},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.45451873540878296},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.41016483306884766},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.405851811170578},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3821689188480377},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1406448483467102}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-4981","doi":"https://doi.org/10.1158/1538-7445.am2019-4981","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-4981","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2887328636","https://openalex.org/W3134773268","https://openalex.org/W3181302845","https://openalex.org/W3195507259","https://openalex.org/W2913472940","https://openalex.org/W2621488969","https://openalex.org/W4362594030","https://openalex.org/W2480783799","https://openalex.org/W2886709162","https://openalex.org/W3034113315"],"abstract_inverted_index":{"Abstract":[0],"HER2-targeted":[1,61,128,143,173,196,229,335,364,413],"antibody":[2,414],"drug":[3,415],"conjugate":[4],"(ADC)":[5],"was":[6,163,344,375],"only":[7,313],"tested":[8],"in":[9,114,156,165,198,220,286,320],"immunocompromised":[10],"(SCID)":[11],"host,":[12],"which":[13,118,343],"doesn\u2019t":[14],"allow":[15],"the":[16,19,72,123,152,177,192,213,224,232,246,266,274,277,289,302,309,315,321,347,434],"evaluation":[17],"of":[18,29,74,101,127,179,195,216,234,288,304,317,349,354,433],"ADC-induced":[20],"host":[21,65,133,340,419],"immune":[22,47,53,66,134,218,341],"responses.":[23,135],"In":[24,136,168],"addition,":[25],"no":[26],"potential":[27],"impact":[28],"ADC":[30,62,75,144,174,197,207,230,297,336,365],"on":[31],"cancer":[32,369,422],"stem":[33,370,423],"cells":[34,41,55,182,254,291,424],"(CSCs)":[35],"has":[36],"been":[37],"reported.":[38],"Furthermore,":[39],"tumor":[40,93,113,148,203,221,238,247,253,263,283,290],"with":[42,98,209],"PD-L1":[43],"expression":[44,100],"may":[45],"escape":[46],"attack":[48],"by":[49,79,346,378,428],"converting":[50],"PD-1":[51],"positive":[52,181,306],"effector":[54],"into":[56],"anergy.":[57],"We":[58,185,360],"hypothesized":[59],"that":[60,142,172,187,334,363],"could":[63,76,111,279,337,366],"modulate":[64],"response,":[67],"target":[68,367],"HER2high":[69],"CSCs,":[70],"and":[71,95,104,109,125,130,183,201,236,352,357,372,425],"efficacy":[73,124,194],"be":[77],"enhanced":[78,377,427],"anti-mPD-L1.":[80],"To":[81],"test":[82,122],"this":[83],"hypotheses,":[84],"we":[85,140,170],"used":[86],"two":[87],"immunocompetent":[88,115],"murine":[89],"models:":[90],"mouse":[91,138],"breast":[92],"D2/F2":[94],"TNBC":[96],"4T1":[97],"enforced":[99],"HER2,":[102],"D2F2/E2":[103,108,137,147,200],"HER2-4T1":[105,110,166,202],"respectively.":[106],"Both":[107],"generate":[112],"Balb/c":[116],"mice,":[117],"allowed":[119],"us":[120],"to":[121,131,249,265,282],"specificity":[126,162],"ADC,":[129],"evaluate":[132],"model,":[139],"found":[141,186],"significantly":[145,190,211,255,326,376],"inhibited":[146],"growth,":[149],"but":[150,324],"not":[151,312],"parental":[153],"D2F2":[154],"tumors,":[155],"a":[157,295],"dose":[158],"dependent":[159],"manner.":[160],"The":[161],"confirmed":[164],"model.":[167],"parallel,":[169],"observed":[171],"treatment":[175,251],"reduced":[176,301,314],"number":[178,233,303,316],"HER2":[180,305],"ALDHhighCSCs.":[184],"anti-mPD-L1":[188,227,379],"mAb":[189],"augmented":[191],"therapeutic":[193],"both":[199],"models.":[204],"Mechanistically,":[205],"HER2-targted":[206],"combined":[208,250,267,310],"anti-PD-L1":[210,299,429],"modulated":[212],"gene":[214,350],"signature":[215,351],"multiple":[217],"factors":[219],"microenvironment.":[222],"At":[223],"cellular":[225],"level,":[226],"plus":[228,298],"increased":[231],"CD3+":[235,243,356],"CD19+":[237,260,358],"infiltrating":[239],"lymphocytes":[240],"(TILs).":[241],"Expanded":[242,259],"TILs":[244,261],"from":[245,262],"subjected":[248,264],"killed":[252],"more":[256,270],"than":[257,272],"mono-treatment.":[258],"therapy":[268,311],"produced":[269],"IgG":[271,278],"all":[273],"controls.":[275],"Importantly,":[276,308],"specifically":[280],"bind":[281],"cells,":[284,371],"resulting":[285],"cytotoxicity":[287],"via":[292],"ADCC.":[293],"As":[294],"result,":[296],"further":[300],"cells.":[307],"ALDHhigh":[318,368],"CSCs":[319],"residual":[322],"tumor,":[323],"also":[325],"paralyzed":[327],"their":[328],"tumoriginicity.":[329],"Together,":[330],"our":[331],"data":[332],"indicate":[333],"induce":[338,418],"significant":[339],"responses,":[342],"evidenced":[345],"regulation":[348],"detection":[353],"anti-tumor":[355],"TILs.":[359],"first":[361],"show":[362],"such":[373],"effect":[374],"administration.":[380],"Citation":[381],"Format:":[382],"Leiming":[383],"Xia,":[384],"Lu":[385],"Wen,":[386],"Gang":[387],"Wu,":[388],"Tao":[389],"Zhang,":[390],"Frank":[391],"Comer,":[392],"Mary":[393],"Jane":[394],"Masson":[395],"Hinrichs,":[396],"Michael":[397],"Oberst,":[398],"Steven":[399],"R.":[400],"Coats,":[401],"Alfred":[402],"E.":[403],"Chang,":[404],"Yuanyuan":[405],"Liu,":[406],"Yangyi":[407],"Bao,":[408],"Max":[409],"Wicha,":[410],"Qiao":[411],"Li.":[412],"conjugates":[416],"(ADCs)":[417],"immunity":[420],"against":[421],"are":[426],"[abstract].":[430],"In:":[431],"Proceedings":[432],"American":[435],"Association":[436],"for":[437],"Cancer":[438,452],"Research":[439],"Annual":[440],"Meeting":[441],"2019;":[442],"2019":[443],"Mar":[444],"29-Apr":[445],"3;":[446],"Atlanta,":[447],"GA.":[448],"Philadelphia":[449],"(PA):":[450],"AACR;":[451],"Res":[453],"2019;79(13":[454],"Suppl):Abstract":[455],"nr":[456],"4981.":[457]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2019-07-12T00:00:00"}